“The efficiency of downstream processing determines the ultimate viability of a lead candidate,” says Dr. Simon Hu, Chief Scientific Officer at Creative Biolabs. “Our goal is to provide a seamless ...
Creative Biolabs announces upgraded downstream services designed to bridge the gap between raw antibody expression and advanced preclinical development. SHIRLEY, NY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results